Diagnosis, Diagnostics, Immunodiagnosis & Immunodiagnostics:

9205.  Harith A, Mutasim M, Mansour D, Fadil Mustafa E, Arvidson H. Use of glycerol as an alternative to freeze-drying for long-term preservation of antigen for the direct agglutination test. Trop Med Int Health. 2003 Nov;8(11):1025-9.

9206.  Kopterides P, Halikias S, Tsavaris N. Visceral leishmaniasis masquerading as myelodysplasia. Am J Hematol. 2003 Nov;74(3):198-9.

9207.  Lala S, Nandy AK, Mahato SB, Basu MK: Delivery in vivo of 14-deoxy-11-oxandrographolide, an antileishmanial agent, by different  drug carriers.  Indian J Biochem Biophys 2003; 40(3): 169-74.

9208.  Pantsari MW, Coleman TA. Images in clinical medicine. Kala-azar. N Engl J Med. 2003 Oct 2;349(14):e13.

9209.  Salotra P, Sreenivas G, Beena KR, Mukherjee A, Ramesh V. Parasite detection in patients with post kala-azar dermal leishmaniasis in India: a comparison between molecular and immunological methods. J Clin Pathol. 2003 Nov;56(11):840-3.

Pathogenesis:

9210.  Iannello D, Arena A, Buemi C, Calapai M, Stassi G, Gazzara D, Mastroeni P.  Differential induction of TNFalpha and IL-18 in human peripheral blood mononuclear cells infected with Leishmania major or Leishmania donovani. New Microbiol. 2003 Oct;26(4):399-404.

Vaccines:

9211.  Mahmoodi M, Khamesipour A, Dowlati Y, Rafati S, Momeni AZ, Emamjomeh M, Hejazi H, Modabber F. Immune response measured in human volunteers vaccinated with autoclaved Leishmania major vaccine mixed with low dose of BCG. Clin Exp Immunol. 2003 Nov;134(2):303-8.

Therapy:

9212.  Berman J. Current treatment approaches to leishmaniasis. Curr Opin Infect Dis. 2003 Oct;16(5):397-401. Review.

9213.  Fernandez Cotarelo MJ, Abellan Martinez J, Guerra Vales JM, Martinez Sanchez P, Rodrigo Gomez De La Barcena M, Salto Fernandez E. Effect of highly active antiretroviral therapy on the incidence and clinical manifestations of visceral leishmaniasis in human immunodeficiency virus-infected patients. Clin Infect Dis. 2003 Oct 1;37(7):973-7. Epub 2003 Sep 10.